|
|
| G
|
ABCB1
|
ATP binding cassette subfamily B member 1
|
increases expression decreases activity
|
EXP
|
artemisinin results in increased expression of ABCB1 mRNA artemisinin results in decreased activity of ABCB1 protein
|
CTD |
PMID:15761118 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,375
|
|
| G
|
ABCC3
|
ATP binding cassette subfamily C member 3
|
multiple interactions
|
EXP
|
artemisinin inhibits the reaction [Simvastatin results in increased nitrosation of ABCC3 protein]
|
CTD |
PMID:18463201 |
|
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,609...50,692,631
|
|
| G
|
CASP3
|
caspase 3
|
increases activity increases expression
|
ISO EXP
|
artemisinin results in increased activity of CASP3 protein artemisinin results in increased expression of CASP3 protein
|
CTD |
PMID:17948936 PMID:39778717 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,695...184,650,418
|
|
| G
|
CAT
|
catalase
|
decreases activity
|
ISO
|
artemisinin results in decreased activity of CAT protein
|
CTD |
PMID:24876631 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,906...34,472,061
|
|
| G
|
CD44
|
CD44 molecule (IN blood group)
|
decreases expression
|
EXP
|
artemisinin results in decreased expression of CD44 protein
|
CTD |
PMID:39778717 |
|
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
|
|
| G
|
CDK4
|
cyclin dependent kinase 4
|
decreases expression
|
EXP
|
artemisinin results in decreased expression of CDK4 protein
|
CTD |
PMID:39778717 |
|
NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,722...57,756,013
|
|
| G
|
CHUK
|
component of inhibitor of nuclear factor kappa B kinase complex
|
multiple interactions
|
EXP
|
artemisinin inhibits the reaction [Simvastatin results in increased phosphorylation of CHUK protein]
|
CTD |
PMID:18463201 |
|
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
|
|
| G
|
CYP1A2
|
cytochrome P450 family 1 subfamily A member 2
|
decreases activity increases expression
|
EXP ISO
|
artemisinin results in decreased activity of CYP1A2 protein artemisinin results in increased expression of CYP1A2 mRNA
|
CTD |
PMID:11124226 PMID:16919048 PMID:17962186 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,795...74,756,607
|
|
| G
|
CYP2A6
|
cytochrome P450 family 2 subfamily A member 6
|
increases activity increases expression
|
ISO
|
artemisinin results in increased activity of CYP2A5 protein artemisinin results in increased expression of CYP2A5 mRNA
|
CTD |
PMID:16919048 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,533...40,850,450
|
|
| G
|
CYP2B6
|
cytochrome P450 family 2 subfamily B member 6
|
multiple interactions increases expression increases activity affects metabolic processing
|
EXP ISO
|
[artemisinin results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA artemisinin results in increased expression of CYP2B10 mRNA artemisinin results in increased activity of CYP2B10 protein artemisinin results in increased expression of CYP2B6 mRNA CYP2B6 protein affects the metabolism of artemisinin
|
CTD |
PMID:12920490 PMID:15761118 PMID:16919048 PMID:17041008 PMID:17962186 PMID:18332078 More...
|
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,281...41,018,398
|
|
| G
|
CYP2C19
|
cytochrome P450 family 2 subfamily C member 19
|
decreases activity
|
EXP
|
artemisinin results in decreased activity of CYP2C19 protein
|
CTD |
PMID:11124226 |
|
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,662...94,856,282
|
|
| G
|
CYP2E1
|
cytochrome P450 family 2 subfamily E member 1
|
increases expression
|
ISO
|
artemisinin results in increased expression of CYP2E1 mRNA
|
CTD |
PMID:17962186 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
| G
|
CYP3A4
|
cytochrome P450 family 3 subfamily A member 4
|
multiple interactions affects metabolic processing increases expression
|
EXP
|
[artemisinin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA CYP3A4 protein affects the metabolism of artemisinin artemisinin results in increased expression of CYP3A4 mRNA
|
CTD |
PMID:12920490 PMID:15761118 PMID:17041008 PMID:18332078 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,959...99,784,274
|
|
| G
|
DLG4
|
discs large MAGUK scaffold protein 4
|
multiple interactions
|
ISO
|
artemisinin inhibits the reaction [trimethyltin chloride results in decreased expression of DLG4 protein]
|
CTD |
PMID:36696940 |
|
NCBI chr17:7,187,187...7,220,050
Ensembl chr17:7,187,187...7,219,836
|
|
| G
|
EPCAM
|
epithelial cell adhesion molecule
|
decreases expression
|
EXP
|
artemisinin results in decreased expression of EPCAM protein
|
CTD |
PMID:39778717 |
|
NCBI chr 2:47,369,311...47,387,020
Ensembl chr 2:47,345,158...47,387,601
|
|
| G
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
decreases expression
|
EXP
|
artemisinin results in decreased expression of ERBB2 protein
|
CTD |
PMID:39778717 |
|
NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
|
|
| G
|
ESRRA
|
estrogen related receptor alpha
|
multiple interactions
|
EXP
|
artemisinin inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein]; artemisinin inhibits the reaction [XCT790 results in decreased activity of ESRRA protein]
|
CTD |
PMID:30818834 |
|
NCBI chr11:64,305,524...64,316,743
Ensembl chr11:64,305,080...64,316,744
|
|
| G
|
FSHB
|
follicle stimulating hormone subunit beta
|
decreases expression
|
ISO
|
artemisinin results in decreased expression of FSHB protein
|
CTD |
PMID:24876631 |
|
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
|
|
| G
|
GSTA1
|
glutathione S-transferase alpha 1
|
decreases activity
|
EXP
|
artemisinin results in decreased activity of GSTA1 protein
|
CTD |
PMID:11807801 |
|
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,881
|
|
| G
|
GSTP1
|
glutathione S-transferase pi 1
|
decreases activity
|
EXP
|
artemisinin results in decreased activity of GSTP1 protein
|
CTD |
PMID:11807801 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,658...67,586,659
|
|
| G
|
IDH3A
|
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
|
decreases expression
|
EXP
|
artemisinin results in decreased expression of IDH3A mRNA
|
CTD |
PMID:30818834 |
|
NCBI chr15:78,149,362...78,171,945
Ensembl chr15:78,131,498...78,171,945
|
|
| G
|
IKBKB
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
multiple interactions
|
EXP
|
artemisinin inhibits the reaction [Simvastatin results in increased phosphorylation of IKBKB protein]
|
CTD |
PMID:18463201 |
|
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
|
|
| G
|
IL6
|
interleukin 6
|
increases expression
|
EXP
|
artemisinin results in increased expression of IL6 protein
|
CTD |
PMID:39778717 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
| G
|
LYZ
|
lysozyme
|
multiple interactions
|
EXP
|
[parthenolide co-treated with artemisinin co-treated with Quercetin] inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]; artemisinin inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]
|
CTD |
PMID:23355332 |
|
NCBI chr12:69,348,381...69,354,234
Ensembl chr12:69,348,381...69,354,234
|
|
| G
|
NFKB1
|
nuclear factor kappa B subunit 1
|
multiple interactions
|
EXP
|
artemisinin inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid affects the localization of NFKB1 protein]; artemisinin inhibits the reaction [Simvastatin results in increased localization of and results in increased activity of NFKB1 protein]; artemisinin inhibits the reaction [Simvastatin results in increased localization of NFKB1 protein]
|
CTD |
PMID:18463201 PMID:23355332 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,500,937...102,617,302
|
|
| G
|
NFKBIA
|
NFKB inhibitor alpha
|
multiple interactions
|
EXP
|
artemisinin inhibits the reaction [Simvastatin results in increased phosphorylation of NFKBIA protein]
|
CTD |
PMID:18463201 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
| G
|
NR1I2
|
nuclear receptor subfamily 1 group I member 2
|
multiple interactions
|
EXP
|
[artemisinin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; artemisinin binds to and results in increased activity of NR1I2 protein
|
CTD |
PMID:15761118 PMID:17041008 |
|
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
|
|
| G
|
NR1I3
|
nuclear receptor subfamily 1 group I member 3
|
multiple interactions increases expression affects expression affects localization increases activity
|
EXP ISO
|
[artemisinin results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; artemisinin binds to and results in increased activity of NR1I3 protein; artemisinin binds to and results in increased activity of NR1I3 protein mutant form artemisinin binds to and results in increased activity of NR1I3 protein; fenvalerate inhibits the reaction [artemisinin binds to and results in increased activity of NR1I3 protein] artemisinin results in increased expression of NR1I3 mRNA artemisinin affects the expression of NR1I3 mRNA alternative form artemisinin affects the localization of NR1I3 protein artemisinin results in increased activity of NR1I3 protein; artemisinin results in increased activity of NR1I3 protein alternative form; artemisinin results in increased activity of NR1I3 protein mutant form artemisinin results in increased activity of NR1I3 protein; artemisinin results in increased activity of NR1I3 protein mutant form
|
CTD |
PMID:15761118 PMID:16919048 PMID:17041008 PMID:17962186 PMID:20686338 PMID:21778469 PMID:24721719 PMID:27665777 PMID:27732639 PMID:31472229 PMID:31538121 More...
|
|
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,262
|
|
| G
|
PPARGC1A
|
PPARG coactivator 1 alpha
|
multiple interactions
|
EXP
|
artemisinin inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein]
|
CTD |
PMID:30818834 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
| G
|
PROK2
|
prokineticin 2
|
multiple interactions
|
ISO
|
artemisinin inhibits the reaction [trimethyltin chloride results in increased expression of PROK2 protein]
|
CTD |
PMID:36696940 |
|
NCBI chr 3:71,771,655...71,785,148
Ensembl chr 3:71,771,655...71,785,206
|
|
| G
|
PROKR2
|
prokineticin receptor 2
|
multiple interactions
|
ISO
|
artemisinin inhibits the reaction [trimethyltin chloride results in increased expression of PROKR2 protein]
|
CTD |
PMID:36696940 |
|
NCBI chr20:5,299,218...5,316,954
Ensembl chr20:5,299,218...5,316,954
|
|
| G
|
PTGS2
|
prostaglandin-endoperoxide synthase 2
|
decreases expression
|
EXP
|
artemisinin results in decreased expression of PTGS2 protein
|
CTD |
PMID:39778717 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
| G
|
RELA
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
EXP ISO
|
artemisinin inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid affects the localization of RELA protein]; artemisinin inhibits the reaction [Simvastatin results in increased localization of and results in increased activity of RELA protein]; artemisinin inhibits the reaction [Simvastatin results in increased localization of RELA protein] artemisinin inhibits the reaction [trimethyltin chloride results in increased expression of RELA protein]
|
CTD |
PMID:18463201 PMID:23355332 PMID:36696940 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
| G
|
SLC22A1
|
solute carrier family 22 member 1
|
multiple interactions
|
EXP
|
artemisinin inhibits the reaction [SLC22A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
|
CTD |
PMID:27504015 |
|
NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,159,398
|
|
| G
|
SLC22A2
|
solute carrier family 22 member 2
|
multiple interactions
|
EXP
|
artemisinin inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
|
CTD |
PMID:27504015 |
|
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
|
|
| G
|
SLCO1A2
|
solute carrier organic anion transporter family member 1A2
|
multiple interactions
|
EXP
|
artemisinin inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]
|
CTD |
PMID:27504015 |
|
NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,676
|
|
| G
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
increases expression
|
EXP
|
artemisinin results in increased expression of SRC protein
|
CTD |
PMID:39778717 |
|
NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,673...37,406,050
|
|
| G
|
SYN1
|
synapsin I
|
multiple interactions
|
ISO
|
artemisinin inhibits the reaction [trimethyltin chloride results in decreased expression of SYN1 protein]
|
CTD |
PMID:36696940 |
|
NCBI chr X:47,571,901...47,619,857
Ensembl chr X:47,571,901...47,619,858
|
|
| G
|
SYP
|
synaptophysin
|
multiple interactions
|
ISO
|
artemisinin inhibits the reaction [trimethyltin chloride results in decreased expression of SYP protein]
|
CTD |
PMID:36696940 |
|
NCBI chr X:49,187,815...49,200,193
Ensembl chr X:49,187,807...49,200,218
|
|
| G
|
TNF
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
artemisinin inhibits the reaction [trimethyltin chloride results in increased expression of TNF protein]
|
CTD |
PMID:36696940 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
| G
|
TP53
|
tumor protein p53
|
increases activity increases expression
|
EXP
|
artemisinin results in increased activity of TP53 protein artemisinin results in increased expression of TP53 protein
|
CTD |
PMID:30818834 PMID:39778717 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
|
|
| G
|
CYP2B6
|
cytochrome P450 family 2 subfamily B member 6
|
multiple interactions
|
EXP
|
[Artemether co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA
|
CTD |
PMID:31312845 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,281...41,018,398
|
|
| G
|
NR1I3
|
nuclear receptor subfamily 1 group I member 3
|
affects expression multiple interactions
|
EXP
|
artemether affects the expression of NR1I3 mRNA alternative form [Artemether co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA; Artemether binds to and results in increased activity of NR1I3 protein alternative form
|
CTD |
PMID:24721719 PMID:31312845 |
|
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,262
|
|
| G
|
PRL
|
prolactin
|
increases secretion
|
ISO
|
Artemether results in increased secretion of PRL protein
|
CTD |
PMID:26811345 |
|
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
|
|
|
|
| G
|
NR1I3
|
nuclear receptor subfamily 1 group I member 3
|
affects expression
|
EXP
|
artemotil affects the expression of NR1I3 mRNA alternative form
|
CTD |
PMID:24721719 |
|
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,262
|
|
|
|
| G
|
ACTA2
|
actin alpha 2, smooth muscle
|
multiple interactions decreases expression
|
ISO EXP
|
Artesunate inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] Deferoxamine inhibits the reaction [Artesunate results in decreased expression of ACTA2 mRNA] Artesunate results in decreased expression of ACTA2 mRNA; Artesunate results in decreased expression of ACTA2 protein
|
CTD |
PMID:30551460 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339
|
|
| G
|
AIFM1
|
apoptosis inducing factor mitochondria associated 1
|
affects localization
|
EXP
|
artesunate affects the localization of AIFM1 protein
|
CTD |
PMID:24704559 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
| G
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3C
|
multiple interactions increases expression increases response to substance
|
EXP
|
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of CHEK1 protein]; APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of CHEK2 protein]; APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of H2AX protein] Artesunate results in increased expression of APOBEC3C mRNA; Artesunate results in increased expression of APOBEC3C protein APOBEC3C protein results in increased susceptibility to Artesunate
|
CTD |
PMID:31664825 |
|
NCBI chr22:39,014,257...39,020,352
Ensembl chr22:39,014,224...39,020,352
|
|
| G
|
AR
|
androgen receptor
|
multiple interactions
|
EXP
|
artesunate binds to and results in decreased activity of AR protein
|
CTD |
PMID:25752796 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,543,353...67,730,619
|
|
| G
|
ATG12
|
autophagy related 12
|
increases expression
|
EXP
|
Artesunate results in increased expression of ATG12 mRNA
|
CTD |
PMID:30551460 |
|
NCBI chr 5:115,828,200...115,841,565
Ensembl chr 5:115,828,200...115,841,837
|
|
| G
|
ATG3
|
autophagy related 3
|
increases expression
|
EXP
|
Artesunate results in increased expression of ATG3 mRNA
|
CTD |
PMID:30551460 |
|
NCBI chr 3:112,532,510...112,561,962
Ensembl chr 3:112,532,510...112,562,046
|
|
| G
|
ATG5
|
autophagy related 5
|
increases expression
|
EXP
|
Artesunate results in increased expression of ATG5 mRNA
|
CTD |
PMID:30551460 |
|
NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,326,477
|
|
| G
|
BAX
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
EXP ISO
|
Artesunate results in increased expression of BAX protein [1,2-Dimethylhydrazine co-treated with artesunate] results in increased expression of BAX protein
|
CTD |
PMID:24704559 PMID:29031619 PMID:33002460 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
| G
|
BCL2
|
BCL2 apoptosis regulator
|
decreases expression multiple interactions
|
EXP ISO
|
Artesunate results in decreased expression of BCL2 protein 3-methyladenine inhibits the reaction [Artesunate results in decreased expression of BCL2 protein]; acadesine promotes the reaction [Artesunate results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Artesunate results in decreased expression of BCL2 protein]; dorsomorphin inhibits the reaction [Artesunate results in decreased expression of BCL2 protein]; Sirolimus promotes the reaction [Artesunate results in decreased expression of BCL2 protein] [1,2-Dimethylhydrazine co-treated with artesunate] results in decreased expression of BCL2 protein
|
CTD |
PMID:24704559 PMID:29031619 PMID:33002460 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
| G
|
BST1
|
bone marrow stromal cell antigen 1
|
increases response to substance
|
EXP
|
BST1 mRNA results in increased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr 4:15,703,065...15,774,173
Ensembl chr 4:15,703,000...15,775,614
|
|
| G
|
CASP3
|
caspase 3
|
increases activity multiple interactions increases cleavage
|
EXP
|
artesunate results in increased activity of CASP3 protein 3-methyladenine inhibits the reaction [Artesunate results in increased cleavage of CASP3 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [Artesunate results in increased cleavage of CASP3 protein]; Sirolimus promotes the reaction [Artesunate results in increased cleavage of CASP3 protein]
|
CTD |
PMID:19513562 PMID:24704559 PMID:33002460 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,695...184,650,418
|
|
| G
|
CASP9
|
caspase 9
|
affects expression
|
EXP
|
artesunate affects the expression of CASP9 protein
|
CTD |
PMID:24704559 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
| G
|
CAT
|
catalase
|
increases expression decreases response to substance
|
EXP
|
artesunate results in increased expression of CAT protein CAT protein results in decreased susceptibility to artesunate
|
CTD |
PMID:19513562 PMID:20144594 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,906...34,472,061
|
|
| G
|
CCND1
|
cyclin D1
|
decreases expression
|
ISO
|
Artesunate results in decreased expression of CCND1 protein
|
CTD |
PMID:32633561 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,143...69,654,474
|
|
| G
|
CCNE1
|
cyclin E1
|
decreases expression
|
ISO
|
Artesunate results in decreased expression of CCNE1 protein
|
CTD |
PMID:32633561 |
|
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,471...29,824,313
|
|
| G
|
CCT2
|
chaperonin containing TCP1 subunit 2
|
decreases response to substance
|
EXP
|
CCT2 mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr12:69,585,459...69,601,570
Ensembl chr12:69,585,423...69,601,577
|
|
| G
|
CDK2
|
cyclin dependent kinase 2
|
decreases expression
|
ISO
|
Artesunate results in decreased expression of CDK2 protein
|
CTD |
PMID:32633561 |
|
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
|
|
| G
|
CDK4
|
cyclin dependent kinase 4
|
decreases expression
|
ISO
|
Artesunate results in decreased expression of CDK4 protein
|
CTD |
PMID:32633561 |
|
NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,722...57,756,013
|
|
| G
|
CHEK1
|
checkpoint kinase 1
|
multiple interactions increases phosphorylation
|
EXP
|
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of CHEK1 protein]
|
CTD |
PMID:31664825 |
|
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
|
|
| G
|
CHEK2
|
checkpoint kinase 2
|
multiple interactions increases phosphorylation
|
EXP
|
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of CHEK2 protein]
|
CTD |
PMID:31664825 |
|
NCBI chr22:28,687,742...28,741,834
Ensembl chr22:28,687,738...28,742,422
|
|
| G
|
CLIP4
|
CAP-Gly domain containing linker protein family member 4
|
increases response to substance
|
EXP
|
CLIP4 mRNA results in increased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr 2:29,097,726...29,183,808
Ensembl chr 2:29,095,545...29,199,777
|
|
| G
|
COQ8A
|
coenzyme Q8A
|
decreases response to substance
|
EXP
|
COQ8A mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr 1:226,940,294...226,987,544
Ensembl chr 1:226,938,143...226,987,569
|
|
| G
|
CTNNB1
|
catenin beta 1
|
multiple interactions
|
ISO
|
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein]
|
CTD |
PMID:29031619 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
| G
|
CYP2A6
|
cytochrome P450 family 2 subfamily A member 6
|
affects metabolic processing
|
EXP
|
CYP2A6 protein affects the metabolism of artesunate
|
CTD |
PMID:12920490 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,533...40,850,450
|
|
| G
|
DBH
|
dopamine beta-hydroxylase
|
increases response to substance
|
EXP
|
DBH mRNA results in increased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr 9:133,636,363...133,659,329
Ensembl chr 9:133,636,314...133,659,329
|
|
| G
|
DES
|
desmin
|
multiple interactions decreases expression
|
EXP
|
Deferoxamine inhibits the reaction [Artesunate results in decreased expression of DES mRNA] Artesunate results in decreased expression of DES mRNA; Artesunate results in decreased expression of DES protein
|
CTD |
PMID:30551460 |
|
NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,417,474...219,426,739
|
|
| G
|
ESR1
|
estrogen receptor 1
|
multiple interactions
|
EXP
|
artesunate binds to and results in decreased activity of ESR1 protein
|
CTD |
PMID:25752796 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,651,284...152,129,619
|
|
| G
|
FAS
|
Fas cell surface death receptor
|
increases expression
|
EXP
|
artesunate results in increased expression of FAS protein
|
CTD |
PMID:19513562 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
| G
|
FLNA
|
filamin A
|
increases response to substance
|
EXP
|
FLNA mRNA results in increased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr X:154,348,531...154,374,634
Ensembl chr X:154,348,524...154,374,638
|
|
| G
|
FN1
|
fibronectin 1
|
decreases expression multiple interactions
|
EXP
|
Artesunate results in decreased expression of FN1 mRNA; Artesunate results in decreased expression of FN1 protein Deferoxamine inhibits the reaction [Artesunate results in decreased expression of FN1 mRNA]
|
CTD |
PMID:30551460 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,120
|
|
| G
|
FTH1
|
ferritin heavy chain 1
|
decreases expression multiple interactions
|
EXP
|
Artesunate results in decreased expression of FTH1 mRNA; Artesunate results in decreased expression of FTH1 protein Chloroquine inhibits the reaction [Artesunate results in decreased expression of FTH1 mRNA]
|
CTD |
PMID:30551460 |
|
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
|
|
| G
|
FZD7
|
frizzled class receptor 7
|
increases response to substance
|
EXP
|
FZD7 mRNA results in increased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr 2:202,033,855...202,038,441
Ensembl chr 2:202,033,855...202,038,441
|
|
| G
|
GCLC
|
glutamate-cysteine ligase catalytic subunit
|
affects response to substance decreases response to substance
|
EXP
|
GCLC mRNA affects the susceptibility to artesunate GCLC mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:15796179 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
| G
|
GCLM
|
glutamate-cysteine ligase modifier subunit
|
decreases response to substance
|
EXP
|
GCLM mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:15796179 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,513
|
|
| G
|
GPX4
|
glutathione peroxidase 4
|
decreases activity multiple interactions
|
EXP ISO
|
Artesunate results in decreased activity of GPX4 protein Artesunate inhibits the reaction [Carbon Tetrachloride results in increased expression of GPX4 protein]
|
CTD |
PMID:30551460 |
|
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
|
|
| G
|
GSTM4
|
glutathione S-transferase mu 4
|
affects response to substance
|
EXP
|
GSTM4 mRNA affects the susceptibility to artesunate
|
CTD |
PMID:15796179 |
|
NCBI chr 1:109,656,099...109,667,727
Ensembl chr 1:109,656,099...109,665,496
|
|
| G
|
GSTP1
|
glutathione S-transferase pi 1
|
decreases expression
|
EXP
|
artesunate results in decreased expression of GSTP1 protein
|
CTD |
PMID:19513562 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,658...67,586,659
|
|
| G
|
GSTT2
|
glutathione S-transferase theta 2 (gene/pseudogene)
|
affects response to substance
|
EXP
|
GSTT2 mRNA affects the susceptibility to artesunate
|
CTD |
PMID:15796179 |
|
NCBI chr22:23,980,134...23,983,915
Ensembl chr22:23,980,058...23,983,915
|
|
| G
|
GSTZ1
|
glutathione S-transferase zeta 1
|
affects response to substance
|
EXP
|
GSTZ1 mRNA affects the susceptibility to artesunate
|
CTD |
PMID:15796179 |
|
NCBI chr14:77,321,036...77,331,597
Ensembl chr14:77,320,996...77,331,597
|
|
| G
|
H2AX
|
H2A.X variant histone
|
multiple interactions increases phosphorylation
|
EXP
|
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of H2AX protein]
|
CTD |
PMID:31664825 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
| G
|
IL1B
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
artesunate inhibits the reaction [Ethanol results in increased expression of IL1B protein]; artesunate inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; artesunate inhibits the reaction [Glucose results in increased secretion of IL1B protein]
|
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
| G
|
IL6
|
interleukin 6
|
multiple interactions
|
ISO
|
artesunate inhibits the reaction [Ethanol results in increased expression of IL6 protein]; artesunate inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; artesunate inhibits the reaction [Glucose results in increased secretion of IL6 protein]
|
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
| G
|
ITGB1
|
integrin subunit beta 1
|
increases response to substance
|
EXP
|
ITGB1 mRNA results in increased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
|
|
| G
|
MAP1LC3B
|
microtubule associated protein 1 light chain 3 beta
|
multiple interactions increases lipidation
|
EXP
|
3-methyladenine inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; acadesine promotes the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; dorsomorphin inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; Sirolimus promotes the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]
|
CTD |
PMID:33002460 |
|
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,405,090
|
|
| G
|
MGST3
|
microsomal glutathione S-transferase 3
|
affects response to substance
|
EXP
|
MGST3 mRNA affects the susceptibility to artesunate
|
CTD |
PMID:15796179 |
|
NCBI chr 1:165,631,234...165,656,136
Ensembl chr 1:165,630,874...165,661,796
|
|
| G
|
MKI67
|
marker of proliferation Ki-67
|
multiple interactions
|
ISO
|
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]
|
CTD |
PMID:29031619 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,448
|
|
| G
|
MMP9
|
matrix metallopeptidase 9
|
multiple interactions decreases expression
|
ISO EXP
|
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MMP9 protein] Artesunate results in decreased expression of MMP9 mRNA Chloroquine inhibits the reaction [Artesunate results in decreased expression of MMP9 mRNA]
|
CTD |
PMID:29031619 PMID:30551460 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
| G
|
MPO
|
myeloperoxidase
|
multiple interactions
|
ISO
|
artesunate inhibits the reaction [Ethanol results in increased activity of MPO protein]
|
CTD |
PMID:27474069 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
| G
|
MTHFD2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
|
decreases response to substance
|
EXP
|
MTHFD2 mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr 2:74,198,615...74,217,565
Ensembl chr 2:74,186,172...74,217,565
|
|
| G
|
MTOR
|
mechanistic target of rapamycin kinase
|
multiple interactions decreases phosphorylation
|
EXP
|
acadesine promotes the reaction [Artesunate results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Artesunate results in decreased phosphorylation of MTOR protein]; dorsomorphin inhibits the reaction [Artesunate results in decreased phosphorylation of MTOR protein]
|
CTD |
PMID:33002460 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,531...11,262,556
|
|
| G
|
MYD88
|
MYD88 innate immune signal transduction adaptor
|
multiple interactions
|
ISO
|
artesunate inhibits the reaction [Glucose results in increased expression of MYD88 protein]
|
CTD |
PMID:30031708 |
|
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
|
|
| G
|
NACA
|
nascent polypeptide associated complex subunit alpha
|
decreases response to substance
|
EXP
|
NACA mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr12:56,712,427...56,725,299
Ensembl chr12:56,712,305...56,731,628
|
|
| G
|
NCKAP1
|
NCK associated protein 1
|
increases response to substance
|
EXP
|
NCKAP1 mRNA results in increased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr 2:182,909,115...183,038,457
Ensembl chr 2:182,909,115...183,038,858
|
|
| G
|
NCOA4
|
nuclear receptor coactivator 4
|
multiple interactions decreases expression
|
EXP
|
Chloroquine inhibits the reaction [Artesunate results in decreased expression of NCOA4 mRNA] Artesunate results in decreased expression of NCOA4 mRNA; Artesunate results in decreased expression of NCOA4 protein
|
CTD |
PMID:30551460 |
|
NCBI chr10:46,005,088...46,030,623
Ensembl chr10:46,005,085...46,030,669
|
|
| G
|
NFE2L2
|
NFE2 like bZIP transcription factor 2
|
affects localization
|
EXP
|
artesunate affects the localization of NFE2L2 protein
|
CTD |
PMID:26340163 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
| G
|
NLRP3
|
NLR family pyrin domain containing 3
|
multiple interactions
|
ISO
|
artesunate inhibits the reaction [Glucose results in increased expression of NLRP3 protein]
|
CTD |
PMID:30031708 |
|
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,668
|
|
| G
|
PARP1
|
poly(ADP-ribose) polymerase 1
|
increases cleavage multiple interactions
|
EXP
|
Artesunate results in increased cleavage of PARP1 protein 3-methyladenine inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; acadesine promotes the reaction [Artesunate results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; dorsomorphin inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; Sirolimus promotes the reaction [Artesunate results in increased cleavage of PARP1 protein]
|
CTD |
PMID:24704559 PMID:33002460 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
| G
|
PCNA
|
proliferating cell nuclear antigen
|
multiple interactions
|
ISO
|
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein]
|
CTD |
PMID:29031619 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
| G
|
PGR
|
progesterone receptor
|
multiple interactions
|
EXP
|
artesunate binds to and results in increased activity of PGR protein
|
CTD |
PMID:25752796 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
| G
|
PTGS2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO
|
[Carbon Tetrachloride results in increased susceptibility to Artesunate] which results in increased expression of PTGS2 mRNA; [Carbon Tetrachloride results in increased susceptibility to Artesunate] which results in increased expression of PTGS2 protein
|
CTD |
PMID:30551460 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
| G
|
RELA
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
artesunate inhibits the reaction [Ethanol results in increased expression of RELA protein]; artesunate inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]
|
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
| G
|
RPA2
|
replication protein A2
|
increases phosphorylation
|
EXP
|
Artesunate results in increased phosphorylation of RPA2 protein
|
CTD |
PMID:31664825 |
|
NCBI chr 1:27,891,524...27,914,797
Ensembl chr 1:27,891,524...27,914,746
|
|
| G
|
RPL29P2
|
ribosomal protein L29 pseudogene 2
|
decreases response to substance
|
EXP
|
RPL29P2 mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr17:7,754,320...7,754,976
Ensembl chr17:7,754,394...7,754,853 Ensembl chr17:7,754,394...7,754,853
|
|
| G
|
RPL41
|
ribosomal protein L41
|
decreases response to substance
|
EXP
|
RPL41 mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr12:56,116,633...56,117,967
Ensembl chr12:56,116,590...56,117,967
|
|
| G
|
RPL6
|
ribosomal protein L6
|
decreases response to substance
|
EXP
|
RPL6 mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr12:112,405,181...112,418,835
Ensembl chr12:112,405,170...112,418,844
|
|
| G
|
RPL7
|
ribosomal protein L7
|
decreases response to substance
|
EXP
|
RPL7 mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr 8:73,290,242...73,294,466
Ensembl chr 8:73,290,242...73,295,789
|
|
| G
|
RPS12
|
ribosomal protein S12
|
decreases response to substance
|
EXP
|
RPS12 mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr 6:132,814,569...132,817,564
Ensembl chr 6:132,814,557...132,817,577
|
|
| G
|
RPS15A
|
ribosomal protein S15a
|
decreases response to substance
|
EXP
|
RPS15A mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr16:18,781,295...18,790,334
Ensembl chr16:18,781,295...18,790,383
|
|
| G
|
RPS6
|
ribosomal protein S6
|
decreases response to substance
|
EXP
|
RPS6 mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr 9:19,375,715...19,380,236
Ensembl chr 9:19,375,715...19,380,282
|
|
| G
|
SLC25A19
|
solute carrier family 25 member 19
|
decreases response to substance
|
EXP
|
SLC25A19 mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr17:75,272,992...75,289,433
Ensembl chr17:75,272,012...75,289,968
|
|
| G
|
SP1
|
Sp1 transcription factor
|
decreases expression
|
EXP
|
artesunate results in decreased expression of SP1 protein
|
CTD |
PMID:19513562 |
|
NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
|
|
| G
|
SQSTM1
|
sequestosome 1
|
multiple interactions decreases expression
|
EXP
|
Chloroquine inhibits the reaction [Artesunate results in decreased expression of SQSTM1 protein] Artesunate results in decreased expression of SQSTM1 mRNA; Artesunate results in decreased expression of SQSTM1 protein
|
CTD |
PMID:30551460 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
| G
|
SRSF2
|
serine and arginine rich splicing factor 2
|
decreases response to substance
|
EXP
|
SRSF2 mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr17:76,734,115...76,737,411
Ensembl chr17:76,734,115...76,737,395
|
|
| G
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
multiple interactions increases expression
|
EXP
|
Chloroquine inhibits the reaction [Artesunate results in increased expression of TIMP1 mRNA]
|
CTD |
PMID:30551460 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
| G
|
TLR4
|
toll like receptor 4
|
multiple interactions
|
ISO
|
artesunate inhibits the reaction [Glucose results in increased expression of TLR4 protein]
|
CTD |
PMID:30031708 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
| G
|
TNF
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
artesunate inhibits the reaction [Ethanol results in increased expression of TNF protein]; artesunate inhibits the reaction [Glucose results in increased expression of TNF mRNA]; artesunate inhibits the reaction [Glucose results in increased secretion of TNF protein]
|
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
| G
|
TP53
|
tumor protein p53
|
multiple interactions increases expression
|
EXP
|
Artesunate inhibits the reaction [TPT1 protein binds to TP53 protein] Artesunate results in increased expression of TP53 protein
|
CTD |
PMID:33259807 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
| G
|
TPT1
|
tumor protein, translationally-controlled 1
|
affects response to substance multiple interactions
|
EXP
|
TPT1 protein affects the susceptibility to artesunate Artesunate binds to and results in decreased expression of TPT1 protein; Artesunate inhibits the reaction [TPT1 protein binds to TP53 protein]
|
CTD |
PMID:15878303 PMID:33259807 |
|
NCBI chr13:45,333,471...45,341,183
Ensembl chr13:45,333,471...45,341,284
|
|
| G
|
TUFM
|
Tu translation elongation factor, mitochondrial
|
decreases response to substance
|
EXP
|
TUFM mRNA results in decreased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr16:28,842,411...28,846,348
Ensembl chr16:28,842,410...28,846,419
|
|
| G
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
increases phosphorylation multiple interactions
|
EXP
|
Artesunate results in increased phosphorylation of ULK1 protein acadesine promotes the reaction [Artesunate results in increased phosphorylation of ULK1 protein]; Acetylcysteine inhibits the reaction [Artesunate results in increased phosphorylation of ULK1 protein]; dorsomorphin inhibits the reaction [Artesunate results in increased phosphorylation of ULK1 protein]
|
CTD |
PMID:33002460 |
|
NCBI chr12:131,894,622...131,923,150
Ensembl chr12:131,894,621...131,923,161
|
|
| G
|
VEGFA
|
vascular endothelial growth factor A
|
multiple interactions
|
ISO
|
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of VEGFA protein]
|
CTD |
PMID:29031619 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
| G
|
YY1
|
YY1 transcription factor
|
decreases expression
|
EXP
|
artesunate results in decreased expression of YY1 protein
|
CTD |
PMID:19513562 |
|
NCBI chr14:100,239,144...100,282,788
Ensembl chr14:100,238,298...100,282,788
|
|
| G
|
ZBTB4
|
zinc finger and BTB domain containing 4
|
increases response to substance
|
EXP
|
ZBTB4 mRNA results in increased susceptibility to artesunate
|
CTD |
PMID:20144594 |
|
NCBI chr17:7,459,378...7,484,249
Ensembl chr17:7,459,366...7,484,263
|
|
|
|
| G
|
ERCC6
|
ERCC excision repair 6, chromatin remodeling factor
|
affects response to substance
|
EXP
|
ERCC6 protein affects the susceptibility to ascaridole
|
CTD |
PMID:22280988 |
|
NCBI chr10:49,434,881...49,539,538
Ensembl chr10:49,454,168...49,539,538
|
|
| G
|
XPC
|
XPC complex subunit, DNA damage recognition and repair factor
|
affects response to substance
|
EXP
|
XPC protein affects the susceptibility to ascaridole
|
CTD |
PMID:22280988 |
|
NCBI chr 3:14,145,147...14,178,601
Ensembl chr 3:14,145,145...14,178,652
|
|
|
|
| G
|
AKT1
|
AKT serine/threonine kinase 1
|
increases expression multiple interactions
|
ISO
|
Carbon Dioxide results in increased expression of AKT1 protein 3-n-butylphthalide promotes the reaction [Carbon Dioxide results in increased expression of AKT1 protein]
|
CTD |
PMID:37661366 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,348...104,799,934
|
|
| G
|
BCL2
|
BCL2 apoptosis regulator
|
increases expression multiple interactions
|
ISO
|
Carbon Dioxide results in increased expression of BCL2 protein 3-n-butylphthalide promotes the reaction [Carbon Dioxide results in increased expression of BCL2 protein]
|
CTD |
PMID:37661366 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
| G
|
BDNF
|
brain derived neurotrophic factor
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein]
|
CTD |
PMID:24718106 |
|
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
|
|
| G
|
CALCA
|
calcitonin related polypeptide alpha
|
multiple interactions increases secretion
|
ISO
|
Carbon Dioxide inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; Carbon Dioxide inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]; Carbon Dioxide inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased secretion of CALCA protein] Carbon Dioxide results in increased secretion of CALCA protein
|
CTD |
PMID:18052948 |
|
NCBI chr11:14,966,668...14,972,351
Ensembl chr11:14,966,622...14,972,354
|
|
| G
|
CAMK2B
|
calcium/calmodulin dependent protein kinase II beta
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein]
|
CTD |
PMID:24718106 |
|
NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,209,993...44,334,577
|
|
| G
|
CREB1
|
cAMP responsive element binding protein 1
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein]
|
CTD |
PMID:24718106 |
|
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
|
|
| G
|
CRH
|
corticotropin releasing hormone
|
increases response to substance
|
EXP
|
CRH protein results in increased susceptibility to Carbon Dioxide
|
CTD |
PMID:8957205 |
|
NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
|
|
| G
|
DLG3
|
discs large MAGUK scaffold protein 3
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein]
|
CTD |
PMID:24718106 |
|
NCBI chr X:70,444,835...70,505,490
Ensembl chr X:70,444,835...70,505,490
|
|
| G
|
GRIN2B
|
glutamate ionotropic receptor NMDA type subunit 2B
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein]
|
CTD |
PMID:24718106 |
|
NCBI chr12:13,537,337...13,982,134
Ensembl chr12:13,437,942...13,982,002
|
|
| G
|
IL2
|
interleukin 2
|
increases expression multiple interactions
|
EXP ISO
|
Carbon Dioxide results in increased expression of IL2 protein 3-n-butylphthalide promotes the reaction [Carbon Dioxide results in increased expression of IL2 mRNA]; 3-n-butylphthalide promotes the reaction [Carbon Dioxide results in increased expression of IL2 protein] Carbon Dioxide results in increased expression of IL2 mRNA; Carbon Dioxide results in increased expression of IL2 protein
|
CTD |
PMID:37661366 |
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
| G
|
MAPK1
|
mitogen-activated protein kinase 1
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK1 mRNA; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK1 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK1 mRNA]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:24718106 PMID:25004876 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,755,537...21,867,680
|
|
| G
|
MAPK3
|
mitogen-activated protein kinase 3
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK3 mRNA; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK3 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK3 mRNA]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:24718106 PMID:25004876 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
| G
|
MIR29A
|
microRNA 29a
|
multiple interactions
|
EXP
|
[[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of Carbon Dioxide] which results in increased expression of MIR29A mRNA
|
CTD |
PMID:29980036 |
|
NCBI chr 7:130,876,747...130,876,810
Ensembl chr 7:130,876,747...130,876,810
|
|
| G
|
NEIL1
|
nei like DNA glycosylase 1
|
affects abundance
|
ISO
|
NEIL1 affects the abundance of Carbon Dioxide
|
CTD |
PMID:21285402 |
|
NCBI chr15:75,347,039...75,357,115
Ensembl chr15:75,346,878...75,357,115
|
|
| G
|
NGB
|
neuroglobin
|
affects binding
|
ISO
|
Carbon Dioxide binds to [Heme binds to NGB protein]
|
CTD |
PMID:16684569 |
|
NCBI chr14:77,265,483...77,271,206
Ensembl chr14:77,265,483...77,271,206
|
|
| G
|
PPARA
|
peroxisome proliferator activated receptor alpha
|
multiple interactions
|
ISO
|
PPARA protein promotes the reaction [[GW 7647 results in increased oxidation of Palmitic Acid] which results in increased abundance of Carbon Dioxide]
|
CTD |
PMID:21324916 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,149,924...46,243,755
|
|
| G
|
RAPGEF3
|
Rap guanine nucleotide exchange factor 3
|
multiple interactions
|
ISO
|
[RAPGEF3 protein affects the susceptibility to Dietary Fats] which affects the chemical synthesis of Carbon Dioxide
|
CTD |
PMID:27381457 |
|
NCBI chr12:47,734,363...47,758,880
Ensembl chr12:47,734,363...47,771,040
|
|
| G
|
SLC9A1
|
solute carrier family 9 member A1
|
affects response to substance
|
ISO
|
SLC9A1 protein affects the susceptibility to Carbon Dioxide
|
CTD |
PMID:16831598 |
|
NCBI chr 1:27,098,809...27,155,125
Ensembl chr 1:27,098,809...27,166,981
|
|
| G
|
SOD1
|
superoxide dismutase 1
|
multiple interactions
|
EXP
|
[[[Bicarbonates co-treated with Carbon Dioxide] promotes the reaction [SOD1 protein binds to peroxycarbonic acid]] which results in increased reduction of peroxycarbonic acid] which results in increased chemical synthesis of Carbonates; [[Bicarbonates co-treated with Carbon Dioxide] promotes the reaction [SOD1 protein binds to peroxycarbonic acid]] which results in increased reduction of peroxycarbonic acid; [[SOD1 protein results in increased metabolism of Hydrogen Peroxide] results in increased oxidation of [Bicarbonates co-treated with Carbon Dioxide]] which results in increased chemical synthesis of Carbonates; [Bicarbonates co-treated with Carbon Dioxide] promotes the reaction [SOD1 protein binds to peroxycarbonic acid]; [Bicarbonates co-treated with Carbon Dioxide] promotes the reaction [SOD1 protein results in increased metabolism of Hydrogen Peroxide]; [SOD1 protein results in increased metabolism of Hydrogen Peroxide] results in increased oxidation of [Bicarbonates co-treated with Carbon Dioxide]
|
CTD |
PMID:19243126 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,633...31,668,931
|
|
| G
|
SYNCRIP
|
synaptotagmin binding cytoplasmic RNA interacting protein
|
multiple interactions
|
EXP
|
[[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of Carbon Dioxide] which affects the expression of SYNCRIP mRNA
|
CTD |
PMID:29980036 |
|
NCBI chr 6:85,607,784...85,643,870
Ensembl chr 6:85,607,779...85,644,063
|
|
| G
|
SYNGAP1
|
synaptic Ras GTPase activating protein 1
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of SYNGAP1 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of SYNGAP1 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of SYNGAP1 protein]
|
CTD |
PMID:24718106 |
|
NCBI chr 6:33,418,167...33,453,689
Ensembl chr 6:33,419,661...33,453,689
|
|
| G
|
TPI1
|
triosephosphate isomerase 1
|
increases expression
|
ISO
|
Carbon Dioxide results in increased expression of TPI1 mRNA
|
CTD |
PMID:14762718 |
|
NCBI chr12:6,867,420...6,870,948
Ensembl chr12:6,867,119...6,870,948
|
|
| G
|
TRH
|
thyrotropin releasing hormone
|
increases response to substance
|
EXP
|
TRH protein results in increased susceptibility to Carbon Dioxide
|
CTD |
PMID:8957205 |
|
NCBI chr 3:129,974,720...129,977,935
Ensembl chr 3:129,974,688...129,977,935
|
|
| G
|
TRPA1
|
transient receptor potential cation channel subfamily A member 1
|
increases activity
|
ISO
|
Carbon Dioxide results in increased activity of TRPA1 protein
|
CTD |
PMID:20881114 |
|
NCBI chr 8:72,021,250...72,090,010
Ensembl chr 8:72,019,608...72,089,998
|
|
| G
|
TRPV1
|
transient receptor potential cation channel subfamily V member 1
|
affects response to substance
|
ISO
|
TRPV1 protein affects the susceptibility to Carbon Dioxide
|
CTD |
PMID:16831598 |
|
NCBI chr17:3,565,446...3,609,411
Ensembl chr17:3,565,444...3,609,411
|
|
|
|
| G
|
ABCC2
|
ATP binding cassette subfamily C member 2
|
increases activity
|
ISO
|
Carbon Monoxide results in increased activity of ABCC2 protein
|
CTD |
PMID:13678533 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
| G
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
multiple interactions increases expression
|
ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased activity of CASP3 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein; [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased expression of PECAM1 protein; Carbon Monoxide results in increased expression of ADIPOQ protein
|
CTD |
PMID:19356108 |
|
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
| G
|
ADM
|
adrenomedullin
|
increases expression
|
ISO
|
Carbon Monoxide results in increased expression of ADM mRNA; Carbon Monoxide results in increased expression of ADM protein
|
CTD |
PMID:10666155 |
|
NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,303,392...10,307,397
|
|
| G
|
AGR2
|
anterior gradient 2, protein disulphide isomerase family member
|
multiple interactions
|
ISO
|
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of AGR2 mRNA
|
CTD |
PMID:29621558 |
|
NCBI chr 7:16,791,811...16,804,999
Ensembl chr 7:16,791,387...16,833,433
|
|
| G
|
AGT
|
angiotensinogen
|
decreases response to substance
|
ISO
|
AGT protein results in decreased susceptibility to Carbon Monoxide
|
CTD |
PMID:18174886 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
| G
|
AKT1
|
AKT serine/threonine kinase 1
|
multiple interactions increases phosphorylation
|
ISO EXP
|
AKT1 protein affects the reaction [Carbon Monoxide results in increased localization of NRF1 protein]; Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein]; Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein; CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of AKT1 protein] Carbon Monoxide inhibits the reaction [IL18 protein results in decreased phosphorylation of AKT1 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein; Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein; CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein]
|
CTD |
PMID:17179207 PMID:18037988 PMID:18215737 PMID:18845810 PMID:19356108 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,348...104,799,934
|
|
| G
|
ALAD
|
aminolevulinate dehydratase
|
multiple interactions increases activity
|
ISO
|
Carbon Monoxide inhibits the reaction [[Phenobarbital co-treated with bromobenzene] results in decreased activity of ALAD protein] Carbon Monoxide results in increased activity of ALAD protein
|
CTD |
PMID:1032310 PMID:6740708 |
|
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,304...113,401,356
|
|
| G
|
AREG
|
amphiregulin
|
multiple interactions
|
ISO
|
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in decreased expression of AREG mRNA
|
CTD |
PMID:29621558 |
|
NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,444,999...74,455,005
|
|
| G
|
BACH1
|
BTB domain and CNC homolog 1
|
decreases phosphorylation
|
ISO
|
Carbon Monoxide results in decreased phosphorylation of BACH1 protein
|
CTD |
PMID:18845810 |
|
NCBI chr21:29,298,922...29,361,894
Ensembl chr21:29,194,071...29,630,751
|
|
| G
|
BAD
|
BCL2 associated agonist of cell death
|
multiple interactions
|
ISO
|
Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of BAD protein]
|
CTD |
PMID:18037988 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,828...64,291,946
|
|
| G
|
BCL2A1
|
BCL2 related protein A1
|
multiple interactions
|
EXP
|
BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; MAPK14 protein affects the reaction [BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]]
|
CTD |
PMID:11880364 |
|
NCBI chr15:79,960,892...79,971,196
Ensembl chr15:79,960,892...79,971,196
|
|
| G
|
BDNF
|
brain derived neurotrophic factor
|
multiple interactions decreases expression
|
ISO
|
Carbon Monoxide results in decreased expression of and results in decreased secretion of BDNF protein Carbon Monoxide results in decreased expression of BDNF mRNA
|
CTD |
PMID:27113706 |
|
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
|
|
| G
|
BIRC3
|
baculoviral IAP repeat containing 3
|
multiple interactions
|
EXP
|
BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; MAPK14 protein affects the reaction [BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]]
|
CTD |
PMID:11880364 |
|
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
|
|
| G
|
CASP3
|
caspase 3
|
multiple interactions increases expression increases activity
|
ISO EXP
|
[Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased activity of CASP3 protein]; Carbon Monoxide inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP3 protein]; Carbon Monoxide results in increased cleavage of and results in increased activity of CASP3 protein; Hemin inhibits the reaction [Carbon Monoxide results in increased cleavage of and results in increased activity of CASP3 protein]; sulforaphane inhibits the reaction [Carbon Monoxide results in increased expression of CASP3 mRNA]; tin protoporphyrin IX inhibits the reaction [Hemin inhibits the reaction [Carbon Monoxide results in increased cleavage of and results in increased activity of CASP3 protein]] Carbon Monoxide results in increased expression of CASP3 protein [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of CASP3 mRNA Carbon Monoxide results in increased activity of CASP3 protein
|
CTD |
PMID:17173083 PMID:19356108 PMID:19520142 PMID:25562542 PMID:31268311 PMID:37860845 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,695...184,650,418
|
|
| G
|
CASP7
|
caspase 7
|
increases activity
|
ISO
|
Carbon Monoxide results in increased activity of CASP7 protein
|
CTD |
PMID:25562542 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,731,290
|
|
| G
|
CASP8
|
caspase 8
|
increases activity multiple interactions
|
ISO EXP
|
Carbon Monoxide results in increased activity of CASP8 protein [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of CASP8 mRNA
|
CTD |
PMID:25562542 PMID:31268311 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
| G
|
CASP9
|
caspase 9
|
increases activity multiple interactions increases expression
|
ISO EXP
|
Carbon Monoxide results in increased activity of CASP9 protein sulforaphane inhibits the reaction [Carbon Monoxide results in increased expression of CASP9 mRNA]; sulforaphane inhibits the reaction [Carbon Monoxide results in increased expression of CASP9 protein] Carbon Monoxide results in increased expression of CASP9 mRNA; Carbon Monoxide results in increased expression of CASP9 protein [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of CASP9 mRNA
|
CTD |
PMID:25562542 PMID:31268311 PMID:37860845 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
| G
|
CAT
|
catalase
|
multiple interactions decreases expression
|
ISO
|
CAT protein inhibits the reaction [Carbon Monoxide results in increased localization of NFE2L2 protein]; CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of AKT1 protein] Carbon Monoxide results in decreased expression of CAT protein CAT protein inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter]]; CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein]; NFE2L2 protein inhibits the reaction [Carbon Monoxide results in decreased expression of CAT protein]
|
CTD |
PMID:17179207 PMID:18845810 PMID:34032369 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,906...34,472,061
|
|
| G
|
CCL1
|
C-C motif chemokine ligand 1
|
multiple interactions
|
ISO
|
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in decreased expression of CCL1 mRNA
|
CTD |
PMID:29621558 |
|
NCBI chr17:34,360,328...34,363,233
Ensembl chr17:34,360,328...34,363,233
|
|
| G
|
CD86
|
CD86 molecule
|
decreases expression
|
ISO
|
Carbon Monoxide results in decreased expression of CD86 protein
|
CTD |
PMID:12201358 |
|
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
| G
|
CLCA1
|
chloride channel accessory 1
|
multiple interactions
|
ISO
|
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of CLCA1 mRNA
|
CTD |
PMID:29621558 |
|
NCBI chr 1:86,468,927...86,500,259
Ensembl chr 1:86,468,368...86,501,400
|
|
| G
|
COL11A1
|
collagen type XI alpha 1 chain
|
multiple interactions
|
ISO
|
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of COL11A1 mRNA
|
CTD |
PMID:29621558 |
|
NCBI chr 1:102,876,473...103,108,522
Ensembl chr 1:102,876,467...103,108,872
|
|
| G
|
CRP
|
C-reactive protein
|
increases expression
|
EXP
|
Carbon Monoxide results in increased expression of CRP protein
|
CTD |
PMID:18629312 |
|
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
| G
|
CXCL11
|
C-X-C motif chemokine ligand 11
|
multiple interactions
|
ISO
|
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of CXCL11 mRNA
|
CTD |
PMID:29621558 |
|
NCBI chr 4:76,033,682...76,036,070
Ensembl chr 4:76,033,682...76,041,415
|
|
| G
|
CYP1A1
|
cytochrome P450 family 1 subfamily A member 1
|
multiple interactions
|
ISO
|
Carbon Monoxide inhibits the reaction [CYP1A1 protein results in increased reduction of sodium chromate(VI)]
|
CTD |
PMID:1903091 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
| G
|
CYP1B1
|
cytochrome P450 family 1 subfamily B member 1
|
multiple interactions
|
ISO
|
Carbon Monoxide promotes the reaction [1-ethynylpyrene results in increased expression of CYP1B1 mRNA]
|
CTD |
PMID:10581206 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
| G
|
CYP2E1
|
cytochrome P450 family 2 subfamily E member 1
|
decreases activity multiple interactions
|
EXP ISO
|
Carbon Monoxide results in decreased activity of CYP2E1 protein Carbon Monoxide inhibits the reaction [CYP2E1 protein results in increased reduction of sodium chromate(VI)]
|
CTD |
PMID:1903091 PMID:15036350 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
| G
|
DNM1L
|
dynamin 1 like
|
increases expression multiple interactions
|
ISO
|
Carbon Monoxide results in increased expression of DNM1L protein sulforaphane inhibits the reaction [Carbon Monoxide results in increased expression of DNM1L protein]
|
CTD |
PMID:37860845 |
|
NCBI chr12:32,679,301...32,745,650
Ensembl chr12:32,679,200...32,745,650
|
|
| G
|
DUOX2
|
dual oxidase 2
|
decreases expression increases expression
|
ISO
|
Carbon Monoxide results in decreased expression of DUOX2 protein Carbon Monoxide results in increased expression of DUOX2 mRNA
|
CTD |
PMID:29223502 |
|
NCBI chr15:45,092,650...45,114,172
Ensembl chr15:45,092,650...45,114,172
|
|
| G
|
EDN1
|
endothelin 1
|
increases expression multiple interactions
|
ISO
|
Carbon Monoxide results in increased expression of EDN1 mRNA; Carbon Monoxide results in increased expression of EDN1 protein Carbon Monoxide deficiency promotes the reaction [HMOX2 mutant form results in increased expression of EDN1 protein]
|
CTD |
PMID:11781074 PMID:12969895 PMID:20197249 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,287,459...12,297,194
|
|
| G
|
EGR1
|
early growth response 1
|
multiple interactions
|
ISO
|
Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 mRNA]; Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 protein]; UCP2 protein promotes the reaction [Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 protein]]
|
CTD |
PMID:22046279 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
| G
|
ENO2
|
enolase 2
|
increases secretion
|
EXP
|
Carbon Monoxide results in increased secretion of ENO2 protein
|
CTD |
PMID:34533065 |
|
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,707
|
|
| G
|
EPO
|
erythropoietin
|
increases expression
|
ISO
|
Carbon Monoxide results in increased expression of EPO mRNA; Carbon Monoxide results in increased expression of EPO protein
|
CTD |
PMID:9263988 |
|
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
|
|
| G
|
ERO1A
|
endoplasmic reticulum oxidoreductase 1 alpha
|
increases expression
|
ISO
|
Carbon Monoxide results in increased expression of ERO1A mRNA
|
CTD |
PMID:12752442 |
|
NCBI chr14:52,639,915...52,695,558
Ensembl chr14:52,639,915...52,696,025
|
|
| G
|
EZR
|
ezrin
|
multiple interactions
|
EXP
|
[[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of Carbon Monoxide] which results in decreased expression of EZR protein
|
CTD |
PMID:37141245 |
|
NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,413
|
|
| G
|
FGB
|
fibrinogen beta chain
|
multiple interactions
|
EXP
|
FGB gene SNP affects the reaction [Carbon Monoxide results in increased expression of IL6 protein]
|
CTD |
PMID:19750100 |
|
NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,562,971...154,572,807
|
|
| G
|
FOXP3
|
forkhead box P3
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of Carbon Monoxide] which affects the methylation of FOXP3 gene; [Air Pollutants results in increased abundance of Carbon Monoxide] which results in increased methylation of FOXP3 promoter
|
CTD |
PMID:29317916 PMID:33603036 |
|
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,436...49,264,800
|
|
| G
|
GABPA
|
GA binding protein transcription factor subunit alpha
|
increases expression multiple interactions
|
ISO
|
Carbon Monoxide results in increased expression of GABPA mRNA Carbon Monoxide results in increased expression of GABPA protein 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of GABPA protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of GABPA protein]; Carbon Monoxide promotes the reaction [GABPA protein binds to TFAM promoter]
|
CTD |
PMID:17179207 |
|
NCBI chr21:25,734,972...25,772,460
Ensembl chr21:25,734,570...25,772,460
|
|
| G
|
GATA4
|
GATA binding protein 4
|
multiple interactions
|
ISO
|
Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased activity of GATA4 protein]
|
CTD |
PMID:18037988 |
|
NCBI chr 8:11,676,935...11,760,002
Ensembl chr 8:11,676,785...11,760,002
|
|
| G
|
GCLC
|
glutamate-cysteine ligase catalytic subunit
|
multiple interactions increases expression
|
ISO
|
[NFE2L2 protein co-treated with Carbon Monoxide] results in increased expression of GCLC mRNA Carbon Monoxide results in increased expression of GCLC mRNA
|
CTD |
PMID:34032369 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
| G
|
GPR182
|
G protein-coupled receptor 182
|
increases expression
|
ISO
|
Carbon Monoxide results in increased expression of GPR182 mRNA
|
CTD |
PMID:10666155 |
|
NCBI chr12:56,994,492...56,998,877
Ensembl chr12:56,994,492...56,998,889
|
|
| G
|
GPX4
|
glutathione peroxidase 4
|
multiple interactions
|
ISO
|
Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased expression of GPX4 protein]
|
CTD |
PMID:18037988 |
|
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
|
|
| G
|
GSK3B
|
glycogen synthase kinase 3 beta
|
multiple interactions increases phosphorylation
|
ISO
|
Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of GSK3B protein] Carbon Monoxide results in increased phosphorylation of GSK3B protein
|
CTD |
PMID:18037988 PMID:18845810 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
| G
|
HMOX1
|
heme oxygenase 1
|
multiple interactions increases chemical synthesis increases expression increases activity
|
ISO EXP
|
Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased expression of HMOX1 protein]; Carbon Monoxide inhibits the reaction [IFNG protein results in decreased expression of HMOX1 protein]; HMOX1 protein affects the reaction [Carbon Monoxide results in increased secretion of IL10 protein]; HMOX1 protein promotes the reaction [Carbon Monoxide results in increased expression of IL22 mRNA]; NFE2L2 protein affects the reaction [Carbon Monoxide results in increased activity of HMOX1 protein]; NFE2L2 protein affects the reaction [Carbon Monoxide results in increased expression of HMOX1 mRNA] HMOX1 protein results in increased chemical synthesis of Carbon Monoxide [HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein; [RELA protein co-treated with REL protein] inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; MAPK14 protein affects the reaction [BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]]; MAPK14 protein affects the reaction [BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]]; RELA protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]] Carbon Monoxide results in increased expression of HMOX1 protein Edaravone promotes the reaction [Carbon Monoxide results in increased expression of HMOX1 protein]; Hemin promotes the reaction [Carbon Monoxide results in increased activity of HMOX1 protein]; Hemin promotes the reaction [Carbon Monoxide results in increased expression of HMOX1 protein]; tin protoporphyrin IX inhibits the reaction [Carbon Monoxide results in increased activity of HMOX1 protein]
|
CTD |
PMID:11880364 PMID:16365149 PMID:18037988 PMID:18845810 PMID:19520142 PMID:21444764 PMID:25348283 PMID:29165873 More...
|
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
| G
|
HMOX2
|
heme oxygenase 2
|
multiple interactions affects chemical synthesis affects abundance
|
ISO
|
Carbon Monoxide deficiency promotes the reaction [HMOX2 mutant form results in increased expression of EDN1 protein] HMOX2 protein affects the chemical synthesis of Carbon Monoxide HMOX2 protein affects the abundance of Carbon Monoxide
|
CTD |
PMID:11342580 PMID:12969895 |
|
NCBI chr16:4,474,736...4,510,347
Ensembl chr16:4,474,246...4,510,352
|
|
| G
|
ICAM1
|
intercellular adhesion molecule 1
|
multiple interactions
|
ISO EXP
|
[Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] Carbon Monoxide inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]
|
CTD |
PMID:19356108 PMID:19608869 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
| G
|
IFNG
|
interferon gamma
|
multiple interactions
|
ISO EXP
|
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in decreased expression of IFNG protein; Carbon Monoxide inhibits the reaction [IFNG protein promotes the reaction [Lipopolysaccharides results in increased expression of IL12B protein]]; Carbon Monoxide inhibits the reaction [IFNG protein results in decreased expression of HMOX1 protein] [Air Pollutants results in increased abundance of Carbon Monoxide] which affects the methylation of IFNG gene; [Air Pollutants results in increased abundance of Carbon Monoxide] which results in increased methylation of IFNG gene
|
CTD |
PMID:16365149 PMID:29621558 PMID:33603036 PMID:35287715 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
| G
|
IGF2BP1
|
insulin like growth factor 2 mRNA binding protein 1
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of Carbon Monoxide] which affects the methylation of IGF2BP1 gene
|
CTD |
PMID:35999615 |
|
NCBI chr17:48,996,558...49,056,145
Ensembl chr17:48,997,225...49,056,145
|
|
| G
|
IL10
|
interleukin 10
|
multiple interactions increases expression
|
ISO EXP
|
Carbon Monoxide promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]; HMOX1 protein affects the reaction [Carbon Monoxide results in increased secretion of IL10 protein] [Air Pollutants results in increased abundance of Carbon Monoxide] which affects the methylation of IL10 gene; [Air Pollutants results in increased abundance of Carbon Monoxide] which results in increased methylation of IL10 gene (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone promotes the reaction [Carbon Monoxide results in increased expression of IL10 protein]; iodopravadoline inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone promotes the reaction [Carbon Monoxide results in increased expression of IL10 protein]] Carbon Monoxide results in increased expression of IL10 mRNA
|
CTD |
PMID:21444764 PMID:31732924 PMID:33603036 PMID:35287715 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
| G
|
IL12B
|
interleukin 12B
|
multiple interactions
|
ISO
|
Carbon Monoxide inhibits the reaction [IFNG protein promotes the reaction [Lipopolysaccharides results in increased expression of IL12B protein]]
|
CTD |
PMID:16365149 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
| G
|
IL13
|
interleukin 13
|
multiple interactions
|
ISO
|
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in decreased expression of IL13 mRNA
|
CTD |
PMID:29621558 |
|
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
| G
|
IL17A
|
interleukin 17A
|
multiple interactions
|
ISO
|
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of IL17A protein
|
CTD |
PMID:29621558 |
|
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
| G
|
IL18
|
interleukin 18
|
decreases response to substance multiple interactions
|
EXP
|
Carbon Monoxide results in decreased susceptibility to IL18 protein Carbon Monoxide inhibits the reaction [IL18 protein results in decreased phosphorylation of AKT1 protein]; Carbon Monoxide inhibits the reaction [IL18 protein results in increased expression of PTEN protein]
|
CTD |
PMID:18215737 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,106
|
|
| G
|
IL1B
|
interleukin 1 beta
|
decreases expression increases expression multiple interactions
|
ISO
|
Carbon Monoxide results in decreased expression of IL1B protein Carbon Monoxide results in increased expression of IL1B protein (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Carbon Monoxide results in increased expression of IL1B protein]; iodopravadoline inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Carbon Monoxide results in increased expression of IL1B protein]]
|
CTD |
PMID:21444764 PMID:31732924 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
| G
|
IL1RL1
|
interleukin 1 receptor like 1
|
increases expression multiple interactions
|
ISO
|
Carbon Monoxide results in increased expression of IL1RL1 protein (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone promotes the reaction [Carbon Monoxide results in increased expression of IL1RL1 protein]; iodopravadoline inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone promotes the reaction [Carbon Monoxide results in increased expression of IL1RL1 protein]]
|
CTD |
PMID:31732924 |
|
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,353
|
|
| G
|
IL22
|
interleukin 22
|
increases expression multiple interactions
|
ISO
|
Carbon Monoxide results in increased expression of IL22 mRNA HMOX1 protein promotes the reaction [Carbon Monoxide results in increased expression of IL22 mRNA]; tin protoporphyrin IX inhibits the reaction [Carbon Monoxide results in increased expression of IL22 mRNA]
|
CTD |
PMID:21444764 |
|
NCBI chr12:68,248,242...68,253,604
Ensembl chr12:68,248,242...68,253,604
|
|
| G
|
IL33
|
interleukin 33
|
increases expression multiple interactions
|
ISO
|
Carbon Monoxide results in increased expression of IL33 protein (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone promotes the reaction [Carbon Monoxide results in increased expression of IL33 protein]; AM 251 inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone promotes the reaction [Carbon Monoxide results in increased expression of IL33 protein]]
|
CTD |
PMID:31732924 |
|
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,136...6,257,983
|
|
| G
|
IL4
|
interleukin 4
|
decreases expression multiple interactions
|
ISO EXP
|
Carbon Monoxide results in decreased expression of IL4 protein [Air Pollutants results in increased abundance of Carbon Monoxide] which affects the methylation of IL4 gene; [Air Pollutants results in increased abundance of Carbon Monoxide] which results in increased methylation of IL4 gene [Carbon Monoxide co-treated with (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone] results in increased expression of IL4 protein; iodopravadoline inhibits the reaction [[Carbon Monoxide co-treated with (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone] results in increased expression of IL4 protein] [Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of IL4 protein
|
CTD |
PMID:21444764 PMID:29621558 PMID:31732924 PMID:33603036 PMID:35287715 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
| G
|
IL6
|
interleukin 6
|
multiple interactions increases expression
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased secretion of IL6 protein; Carbon Monoxide inhibits the reaction [TNF protein results in increased expression of IL6 protein]; FGB gene SNP affects the reaction [Carbon Monoxide results in increased expression of IL6 protein]; IL6 gene SNP affects the reaction [Carbon Monoxide results in increased expression of IL6 protein]
|
CTD |
PMID:18629312 PMID:19608869 PMID:19750100 PMID:31268311 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
| G
|
IRF8
|
interferon regulatory factor 8
|
decreases activity
|
ISO
|
Carbon Monoxide results in decreased activity of IRF8 protein
|
CTD |
PMID:16365149 |
|
NCBI chr16:85,899,162...85,922,609
Ensembl chr16:85,899,116...85,922,606
|
|
| G
|
KEAP1
|
kelch like ECH associated protein 1
|
multiple interactions
|
ISO
|
Carbon Monoxide inhibits the reaction [NFE2L2 protein binds to KEAP1 protein]
|
CTD |
PMID:18845810 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,119...10,503,558
|
|
| G
|
MAPK14
|
mitogen-activated protein kinase 14
|
multiple interactions
|
EXP
|
MAPK14 protein affects the reaction [BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]]; MAPK14 protein affects the reaction [BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]]
|
CTD |
PMID:11880364 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,738...36,122,511
|
|
| G
|
MBP
|
myelin basic protein
|
affects response to substance
|
EXP
|
MBP polymorphism affects the susceptibility to Carbon Monoxide
|
CTD |
PMID:36481359 |
|
NCBI chr18:76,978,833...77,133,708
Ensembl chr18:76,978,827...77,133,683
|
|
| G
|
MFN2
|
mitofusin 2
|
multiple interactions decreases expression
|
ISO
|
sulforaphane affects the reaction [Carbon Monoxide results in decreased expression of MFN2 protein]; sulforaphane inhibits the reaction [Carbon Monoxide results in decreased expression of MFN2 mRNA] Carbon Monoxide results in decreased expression of MFN2 mRNA; Carbon Monoxide results in decreased expression of MFN2 protein
|
CTD |
PMID:37860845 |
|
NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211
|
|
| G
|
MIR1224
|
microRNA 1224
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIR1224 mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr 3:184,241,405...184,241,489
Ensembl chr 3:184,241,405...184,241,489
|
|
| G
|
MIR186
|
microRNA 186
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIR186 mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr 1:71,067,631...71,067,716
Ensembl chr 1:71,067,631...71,067,716
|
|
| G
|
MIR197
|
microRNA 197
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIR197 mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr 1:109,598,893...109,598,967
Ensembl chr 1:109,598,893...109,598,967
|
|
| G
|
MIR21
|
microRNA 21
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIR21 mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
|
|
| G
|
MIR2861
|
microRNA 2861
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIR2861 mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr 9:127,785,918...127,786,007
Ensembl chr 9:127,785,918...127,786,007
|
|
| G
|
MIR342
|
microRNA 342
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIR342 mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr14:100,109,655...100,109,753
Ensembl chr14:100,109,655...100,109,753
|
|
| G
|
MIR3654
|
microRNA 3654
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIR3654 mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr 7:133,034,860...133,034,915
Ensembl chr 7:133,034,860...133,034,915
|
|
| G
|
MIR374B
|
microRNA 374b
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIR374B mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr X:74,218,547...74,218,618
Ensembl chr X:74,218,547...74,218,618
|
|
| G
|
MIR615
|
microRNA 615
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIR615 mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr12:54,033,950...54,034,045
Ensembl chr12:54,033,950...54,034,045
|
|
| G
|
MIR6722
|
microRNA 6722
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIR6722 mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr 9:136,746,893...136,746,970
Ensembl chr 9:136,746,893...136,746,970
|
|
| G
|
MIR93
|
microRNA 93
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIR93 mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr 7:100,093,768...100,093,847
Ensembl chr 7:100,093,768...100,093,847
|
|
| G
|
MIRLET7E
|
microRNA let-7e
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIRLET7E mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr19:51,692,786...51,692,864
Ensembl chr19:51,692,786...51,692,864
|
|
| G
|
MIRLET7I
|
microRNA let-7i
|
multiple interactions
|
EXP
|
[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of MIRLET7I mRNA
|
CTD |
PMID:31268311 |
|
NCBI chr12:62,603,686...62,603,769
Ensembl chr12:62,603,686...62,603,769
|
|
| G
|
MMP9
|
matrix metallopeptidase 9
|
increases expression
|
ISO
|
Carbon Monoxide results in increased expression of MMP9 mRNA
|
CTD |
PMID:20197249 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
| G
|
MRC1
|
mannose receptor C-type 1
|
multiple interactions
|
ISO
|
[(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone co-treated with Carbon Monoxide] results in increased expression of MRC1 protein; iodopravadoline inhibits the reaction [[(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone co-treated with Carbon Monoxide] results in increased expression of MRC1 protein]
|
CTD |
PMID:31732924 |
|
NCBI chr10:17,809,348...17,911,164
Ensembl chr10:17,809,014...17,911,164
|
|
| G
|
NDRG1
|
N-myc downstream regulated 1
|
multiple interactions
|
EXP
|
Carbon Monoxide inhibits the reaction [Oxygen deficiency results in increased expression of NDRG1 mRNA]; Carbon Monoxide inhibits the reaction [Oxygen deficiency results in increased expression of NDRG1 protein]
|
CTD |
PMID:11006124 |
|
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
|
|
| G
|
NFE2L2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions increases expression increases localization decreases phosphorylation
|
ISO
|
Carbon Monoxide inhibits the reaction [NFE2L2 protein binds to KEAP1 protein]; Carbon Monoxide promotes the reaction [NFE2L2 protein binds to NRF1 promoter]; CAT protein inhibits the reaction [Carbon Monoxide results in increased localization of NFE2L2 protein]; NFE2L2 protein affects the reaction [Carbon Monoxide results in increased activity of HMOX1 protein]; NFE2L2 protein affects the reaction [Carbon Monoxide results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [Carbon Monoxide results in increased expression of SOD2 mRNA] Carbon Monoxide results in increased expression of NFE2L2 mRNA; Carbon Monoxide results in increased expression of NFE2L2 protein [NFE2L2 protein co-treated with Carbon Monoxide] results in increased expression of GCLC mRNA; Edaravone promotes the reaction [Carbon Monoxide results in increased expression of NFE2L2 protein]; NFE2L2 protein inhibits the reaction [Carbon Monoxide results in decreased expression of CAT protein]; NFE2L2 protein promotes the reaction [Carbon Monoxide results in increased expression of NFE2L2 mRNA] Carbon Monoxide results in decreased phosphorylation of NFE2L2 protein
|
CTD |
PMID:18845810 PMID:25348283 PMID:34032369 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
| G
|
NFKBIA
|
NFKB inhibitor alpha
|
multiple interactions
|
EXP
|
[RELA protein co-treated with REL protein] inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; MAPK14 protein affects the reaction [BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]]; MAPK14 protein affects the reaction [BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]]; RELA protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]
|
CTD |
PMID:11880364 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
| G
|
NGF
|
nerve growth factor
|
affects expression multiple interactions
|
ISO
|
Carbon Monoxide affects the expression of NGF mRNA Carbon Monoxide results in decreased expression of and affects the secretion of NGF protein
|
CTD |
PMID:27113706 |
|
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
|
|
| G
|
NOS2
|
nitric oxide synthase 2
|
multiple interactions decreases expression
|
ISO
|
Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; PPARG protein promotes the reaction [Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] Carbon Monoxide results in decreased expression of NOS2 protein
|
CTD |
PMID:12201358 PMID:22046279 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,758
|
|
| G
|
NOS3
|
nitric oxide synthase 3
|
multiple interactions
|
ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein
|
CTD |
PMID:19356108 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,015,653
|
|
| G
|
NPPA
|
natriuretic peptide A
|
increases expression
|
ISO
|
Carbon Monoxide results in increased expression of NPPA mRNA
|
CTD |
PMID:11781074 |
|
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
|
|
| G
|
NRF1
|
nuclear respiratory factor 1
|
multiple interactions increases expression increases localization
|
ISO
|
AKT1 protein affects the reaction [Carbon Monoxide results in increased localization of NRF1 protein]; Carbon Monoxide promotes the reaction [NFE2L2 protein binds to NRF1 promoter] Carbon Monoxide results in increased expression of NRF1 protein 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of NRF1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of NRF1 protein]; Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein]; Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter]; CAT protein inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter]] Carbon Monoxide results in increased expression of NRF1 mRNA
|
CTD |
PMID:17179207 PMID:18845810 |
|
NCBI chr 7:129,611,720...129,757,076
Ensembl chr 7:129,611,699...129,757,082
|
|
| G
|
NTF3
|
neurotrophin 3
|
decreases expression multiple interactions
|
ISO
|
Carbon Monoxide results in decreased expression of NTF3 mRNA Carbon Monoxide results in decreased expression of and results in decreased secretion of NTF3 protein
|
CTD |
PMID:27113706 |
|
NCBI chr12:5,430,332...5,495,299
Ensembl chr12:5,432,108...5,521,536
|
|
| G
|
PECAM1
|
platelet and endothelial cell adhesion molecule 1
|
increases expression
|
ISO
|
[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased expression of PECAM1 protein
|
CTD |
PMID:19356108 |
|
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
|
|
| G
|
PLA2G7
|
phospholipase A2 group VII
|
affects expression
|
EXP
|
Carbon Monoxide affects the expression of PLA2G7
|
CTD |
PMID:21356620 |
|
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,718
|
|
| G
|
POLG
|
DNA polymerase gamma, catalytic subunit
|
increases expression
|
ISO
|
Carbon Monoxide results in increased expression of POLG mRNA; Carbon Monoxide results in increased expression of POLG protein
|
CTD |
PMID:17179207 |
|
NCBI chr15:89,316,320...89,334,824
Ensembl chr15:89,305,198...89,334,861
|
|
| G
|
PPARG
|
peroxisome proliferator activated receptor gamma
|
multiple interactions
|
ISO
|
[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein; Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein]; PPARG protein promotes the reaction [Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]
|
CTD |
PMID:22046279 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,574
|
|
| G
|
PPARGC1A
|
PPARG coactivator 1 alpha
|
increases expression multiple interactions
|
ISO
|
Carbon Monoxide results in increased expression of PPARGC1A mRNA Carbon Monoxide results in increased expression of PPARGC1A protein 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of PPARGC1A protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of PPARGC1A protein]; Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein]
|
CTD |
PMID:17179207 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
| G
|
PRG2
|
proteoglycan 2, pro eosinophil major basic protein
|
multiple interactions
|
ISO
|
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of PRG2 mRNA
|
CTD |
PMID:29621558 |
|
NCBI chr11:57,386,780...57,390,650
Ensembl chr11:57,386,780...57,391,143
|
|
| G
|
PRKAA2
|
protein kinase AMP-activated catalytic subunit alpha 2
|
decreases expression multiple interactions
|
ISO
|
Carbon Monoxide results in decreased expression of PRKAA2 mRNA sulforaphane inhibits the reaction [Carbon Monoxide results in decreased expression of PRKAA2 mRNA]
|
CTD |
PMID:37860845 |
|
NCBI chr 1:56,645,314...56,715,335
Ensembl chr 1:56,645,314...56,715,335
|
|
| G
|
PTEN
|
phosphatase and tensin homolog
|
multiple interactions
|
EXP
|
Carbon Monoxide inhibits the reaction [IL18 protein results in increased expression of PTEN protein]
|
CTD |
PMID:18215737 |
|
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
|
|
| G
|
REL
|
REL proto-oncogene, NF-kB subunit
|
multiple interactions
|
EXP
|
[RELA protein co-treated with REL protein] inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]
|
CTD |
PMID:11880364 |
|
NCBI chr 2:60,881,574...60,931,612
Ensembl chr 2:60,881,491...60,931,612
|
|
| G
|
RELA
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
EXP
|
[RELA protein co-treated with REL protein] inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; RELA protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]
|
CTD |
PMID:11880364 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
| G
|
SELP
|
selectin P
|
increases expression
|
EXP
|
Carbon Monoxide results in increased expression of SELP protein modified form
|
CTD |
PMID:18629312 |
|
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,421...169,630,193
|
|
| G
|
SFTPD
|
surfactant protein D
|
multiple interactions
|
EXP
|
[[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of Carbon Monoxide] which results in increased expression of SFTPD protein
|
CTD |
PMID:37141245 |
|
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,128...79,983,996
|
|
| G
|
SOD1
|
superoxide dismutase 1
|
decreases expression
|
EXP
|
Carbon Monoxide results in decreased expression of SOD1 protein
|
CTD |
PMID:18629312 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,633...31,668,931
|
|
| G
|
SOD2
|
superoxide dismutase 2
|
multiple interactions increases expression
|
ISO
|
Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein]; NFE2L2 protein affects the reaction [Carbon Monoxide results in increased expression of SOD2 mRNA] Carbon Monoxide results in increased expression of SOD2 protein
|
CTD |
PMID:17179207 PMID:18037988 PMID:18845810 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
| G
|
SOSTDC1
|
sclerostin domain containing 1
|
multiple interactions
|
ISO
|
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of SOSTDC1 mRNA
|
CTD |
PMID:29621558 |
|
NCBI chr 7:16,461,481...16,465,738
Ensembl chr 7:16,461,481...16,530,580
|
|
| G
|
TFAM
|
transcription factor A, mitochondrial
|
increases expression multiple interactions
|
ISO
|
Carbon Monoxide results in increased expression of TFAM mRNA; Carbon Monoxide results in increased expression of TFAM protein 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of TFAM protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of TFAM protein]; Carbon Monoxide promotes the reaction [GABPA protein binds to TFAM promoter]; Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter]; CAT protein inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter]]
|
CTD |
PMID:17179207 |
|
NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220
|
|
| G
|
TNF
|
tumor necrosis factor
|
multiple interactions increases expression decreases expression decreases response to substance
|
ISO EXP
|
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Carbon Monoxide results in increased expression of TNF protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased activity of CASP3 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Carbon Monoxide inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]; iodopravadoline inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Carbon Monoxide results in increased expression of TNF protein]] Carbon monoxide decreases expression of Tnf mRNA in reperfused liver nonparenchymal cells Carbon Monoxide results in decreased susceptibility to TNF protein [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased secretion of TNF protein; [HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein; [RELA protein co-treated with REL protein] inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; Carbon Monoxide inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Carbon Monoxide inhibits the reaction [TNF protein results in increased expression of IL6 protein]; Carbon Monoxide inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; MAPK14 protein affects the reaction [BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]]; MAPK14 protein affects the reaction [BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]]; RELA protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]] Carbon Monoxide results in decreased expression of TNF protein
|
CTD RGD |
PMID:11880364 PMID:17173083 PMID:19356108 PMID:19608869 PMID:21444764 PMID:31268311 PMID:31732924 PMID:18972563 More...
|
RGD:15023490 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
| G
|
TNFRSF1B
|
TNF receptor superfamily member 1B
|
increases expression
|
EXP
|
Carbon Monoxide results in increased expression of TNFRSF1B protein modified form
|
CTD |
PMID:18629312 |
|
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,977...12,209,228
|
|
| G
|
TNFSF4
|
TNF superfamily member 4
|
multiple interactions
|
ISO
|
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of TNFSF4 mRNA
|
CTD |
PMID:29621558 |
|
NCBI chr 1:173,172,870...173,450,733
Ensembl chr 1:173,162,645...173,477,583
|
|
| G
|
UCP2
|
uncoupling protein 2
|
multiple interactions
|
ISO
|
UCP2 protein promotes the reaction [Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 protein]]; UCP2 protein promotes the reaction [Carbon Monoxide results in increased abundance of Reactive Oxygen Species]
|
CTD |
PMID:22046279 |
|
NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,061...73,983,542
|
|
| G
|
VASP
|
vasodilator stimulated phosphoprotein
|
decreases phosphorylation
|
ISO
|
Carbon Monoxide results in decreased phosphorylation of VASP protein
|
CTD |
PMID:26582457 |
|
NCBI chr19:45,507,479...45,526,983
Ensembl chr19:45,506,579...45,526,991
|
|
| G
|
VCAM1
|
vascular cell adhesion molecule 1
|
multiple interactions
|
EXP ISO
|
Carbon Monoxide inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]
|
CTD |
PMID:19356108 PMID:19608869 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,684...100,739,045
|
|
| G
|
XDH
|
xanthine dehydrogenase
|
increases activity increases metabolic processing
|
ISO
|
Carbon Monoxide results in increased activity of XDH protein Carbon Monoxide results in increased metabolism of XDH protein
|
CTD |
PMID:1447108 |
|
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,320...31,414,747
|
|
|
|
| G
|
CASP3
|
caspase 3
|
increases activity
|
EXP
|
ergosterol-5,8-peroxide results in increased activity of CASP3 protein
|
CTD |
PMID:20100469 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,695...184,650,418
|
|
|
|
| G
|
AKR1C1
|
aldo-keto reductase family 1 member C1
|
increases metabolic processing
|
EXP
|
AKR1C1 protein results in increased metabolism of prostaglandin G2
|
CTD |
PMID:8573067 |
|
NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
|
|
| G
|
PTGS2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions increases abundance
|
ISO
|
[PTGS2 protein results in increased abundance of prostaglandin G2] inhibits the reaction [Sodium Salicylate inhibits the reaction [PTGS2 protein results in increased metabolism of Arachidonic Acid]]; [PTGS2 protein results in increased abundance of prostaglandin G2] inhibits the reaction [Sodium Salicylate results in decreased activity of PTGS2 protein]
|
CTD |
PMID:12538810 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
|
|
| G
|
GSTM2
|
glutathione S-transferase mu 2
|
affects metabolic processing
|
EXP
|
GSTM2 protein affects the metabolism of Prostaglandin H2
|
CTD |
PMID:10905636 |
|
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,667,348...109,709,551
|
|
| G
|
GSTM3
|
glutathione S-transferase mu 3
|
affects metabolic processing
|
EXP
|
GSTM3 protein affects the metabolism of Prostaglandin H2
|
CTD |
PMID:10905636 |
|
NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
|
|
| G
|
PTGDS
|
prostaglandin D2 synthase
|
increases metabolic processing
|
ISO
|
PTGDS protein results in increased metabolism of Prostaglandin H2
|
CTD |
PMID:22043816 |
|
NCBI chr 9:136,977,504...136,981,742
Ensembl chr 9:136,975,053...136,981,750
|
|